These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2236159)

  • 1. Does taurine bind to the insulin binding site of the insulin receptor?
    Kulakowski EC; Maturo J
    Prog Clin Biol Res; 1990; 351():95-102. PubMed ID: 2236159
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding properties of the insulin receptor of human placenta under different conditions of incubation.
    Spallone L; Magnatta R; DePirro R; Lauro R
    Endokrinologie; 1981 Apr; 77(2):226-32. PubMed ID: 7021139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurine binding to the purified insulin receptor.
    Maturo J; Kulakowski EC
    Biochem Pharmacol; 1988 Oct; 37(19):3755-60. PubMed ID: 3052459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nature of the change in insulin receptors on the lymphocytes in a tumor-bearing organism].
    Shelepov VP; Kreslavskaia EE; Shapot VS; Nedosugova LV; Balabolkin MI
    Vopr Med Khim; 1982; 28(4):131-6. PubMed ID: 7051548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
    Misbin RI; Buynitzky SJ; Almira EC
    Drug Metab Dispos; 1982; 10(2):153-5. PubMed ID: 6124401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A14-125I-monoiodoinsulin purified by high performance liquid chromatography (HPLC): cellular receptor binding properties and long-term stability.
    Benzi L; Marchetti P; Cecchetti P; Pezzino V; Gullo D; Masoni A; Navalesi R
    J Nucl Med Allied Sci; 1984; 28(4):277-81. PubMed ID: 6399077
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin receptor degradation is accelerated in cultured lymphocytes from patients with genetic syndromes of extreme insulin resistance.
    McElduff A; Hedo JA; Taylor SI; Roth J; Gorden P
    J Clin Invest; 1984 Oct; 74(4):1366-74. PubMed ID: 6480829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin binding by receptors of the plasma membranes of the liver in hens in ontogenesis].
    Kolychev AP; Leĭbush BN
    Ontogenez; 1988; 19(1):55-8. PubMed ID: 3285282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin receptor interaction in human placental plasma membranes.
    Gómez-Nieto J; Durán-García S
    Rev Esp Fisiol; 1981 Sep; 37(3):269-76. PubMed ID: 6275467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin uptake and receptor reutilization. Symposium summary.
    Fed Proc; 1983 Jun; 42(9):2553-60. PubMed ID: 6343123
    [No Abstract]   [Full Text] [Related]  

  • 11. Affinity modulation of human placental insulin and insulin-like growth factor receptors by lectins.
    Masnikosa R; Nikolić A; Nedić O
    J Biochem; 2008 Jun; 143(6):813-20. PubMed ID: 18316333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of phenformin and other adenosine triphosphate (ATP)-lowering agents on insulin binding to IM-9 human cultured lymphocytes.
    Vigneri R; Maddux B; Goldfine ID
    J Cell Biochem; 1984; 24(2):177-86. PubMed ID: 6327744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadate enhances insulin-receptor binding in gestational diabetic human placenta.
    al-Attas OS; al-Dagheri NM; Vigo NT
    Cell Biochem Funct; 1995 Mar; 13(1):9-14. PubMed ID: 7720193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative dissimilarities of insulin and proinsulin binding and action in vitro at IM 9-lymphocytes.
    Rausch UW; Fussgänger RD; Heinze E
    Horm Metab Res Suppl; 1988; 18():89-92. PubMed ID: 3056819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific binding of 125I-insulin by fat cell plasma membranes in acromegaly].
    Efimov AS; Bezdrobnyĭ IuV; Evdokimova NIu; Komissarenko IV; Demchenko NP
    Vopr Med Khim; 1981; 27(5):644-7. PubMed ID: 7032063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-naphthoflavone on insulin receptor binding and protein kinase activity in rat liver and placenta.
    Wang SL; Raizada MK; Shiverick KT
    Mol Pharmacol; 1988 Mar; 33(3):250-6. PubMed ID: 2832720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of volume-activated taurine and iodide efflux from term human placental tissue.
    Shennan DB
    Placenta; 1999; 20(5-6):485-91. PubMed ID: 10419814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and synthesis of an insulin-binding region on human insulin receptor.
    Nakamura S; Sakata S; Atassi MZ
    J Protein Chem; 1990 Apr; 9(2):229-33. PubMed ID: 2201312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of antibodies that inhibit the binding of insulin to its receptor.
    Roth RA; Wong KY; Maddux BA; Goldfine ID
    Biochem Biophys Res Commun; 1981 Aug; 101(3):979-87. PubMed ID: 7030332
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of serum insulin complexes on the uptake and normal utilization of insulin by isolated tissues and organs.
    Antoniades HN
    Panminerva Med; 1977; 19(2):133-4. PubMed ID: 559280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.